TABLE 1

Definitions for the OME Clinical Performance Measures

Clinical Performance MeasureNumeratorDenominatorDenominator Exclusions
Diagnostic evaluation of tympanic membrane mobility with pneumatic otoscopy or tympanometryNo. of patient visits with documentation of assessment of tympanic membrane mobility with pneumatic otoscopy or tympanometryAll visits for patients aged 2 mo through 12 y with a diagnosis of OME during the study periodDocumentation of medical or patient reason(s) for not assessing tympanic membrane mobility with pneumatic otoscopy or tympanometry
Hearing testingNo. of patients with a hearing evaluation performedAll visits for patients aged 2 months through 12 years with a diagnosis of OME during the study period and OME for greater than 3 months or at risk for speech, language or learning problemsNone
Avoidance of inappropriate antihistamines or decongestant useAll patients aged 2 y or older with a physician visit before 11/2008 and those aged 4 y or older with a physician visit on or after 11/2008, or if younger, the no. of patients who were not prescribed or recommended to receive either antihistamines or decongestantsaAll visits for patients aged 2 mo through 12 y with a diagnosis of OME during the study periodDocumentation of medical reason(s) for prescribing or recommending to receive antihistamines or decongestants
Avoidance of inappropriate systemic antimicrobial agent (antibiotic) useNo. of patients who were not prescribed systemic antimicrobial agentsAll visits for patients aged 2 mo through 12 y with a diagnosis of OME during the study periodDocumentation of medical reason(s) for prescribing systemic antimicrobial agents
Avoidance of inappropriate systemic corticosteroid useNo. of patients who were not prescribed systemic corticosteroidsAll visits for patients aged 2 mo through 12 y with a diagnosis of OME during the study periodDocumentation of medical reason(s) for prescribing systemic corticosteroids
  • a November 2008 Food and Drug Administration recommendations regarding the use of antihistamines and decongestants in children between 2 and 4 years of age.